Literature DB >> 8413965

Type IIa ('anti-Hu') antineuronal antibodies produce destruction of rat cerebellar granule neurons in vitro.

J E Greenlee1, T N Parks, K A Jaeckle.   

Abstract

We reacted dispersed cultures of newborn rat cerebellar granule cells with serum, purified IgG, and CSF from patients with type IIa ("anti-Hu") antibody response accompanying paraneoplastic neurologic syndromes. All type IIa sera, IgGs, and CSFs, but not those of normal or cancer controls, produced bright nuclear immunofluorescence of cultured granule neurons. Type IIa serum and CSF labeled proteins of 35-42 kd in rat granule cell blots, identical in molecular weight to proteins labeled by type IIa antibodies in blots of human granule cells. IgGs eluted from the 35-42 kd band in blots of rat granule cells labeled proteins of similar molecular weights in blots of human granule cells and produced typical type IIa immunostaining of human cerebellar sections. Human IgG could be identified in nuclei and cytoplasm of neurons incubated for 72 hours with 2/4 type IIa sera tested, but not with normal sera. Type IIa sera or IgGs from 4/7 patients produced specific lysis of rat granule cells in the presence of complement, as compared with controls using normal serum or heat-inactivated complement. Prolonged (7-day) incubation of cultures with type IIa antibody without complement also resulted in specific lysis, whereas incubation with normal serum or serum from neurologically normal patients with small-cell carcinoma of the lung did not. Rat granule cell cultures provide a valuable in vitro system with which to study the interaction of type IIa antibody with neurons. The present study provides the first reported evidence that type IIa antibodies may cause cell injury directly, in the absence of lymphocyte-mediated immune response.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8413965     DOI: 10.1212/wnl.43.10.2049

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

Review 1.  Immunological mechanisms in paraneoplastic peripheral neuropathy.

Authors:  J C Antoine
Journal:  Clin Rev Allergy Immunol       Date:  2000-08       Impact factor: 8.667

2.  T cell response to Hu-D peptides in patients with anti-Hu syndrome.

Authors:  A Rousseau; B Benyahia; J Dalmau; F Connan; J-G Guillet; J-Y Delattre; J Choppin
Journal:  J Neurooncol       Date:  2005-02       Impact factor: 4.130

3.  Purkinje cell death after uptake of anti-Yo antibodies in cerebellar slice cultures.

Authors:  John E Greenlee; Susan A Clawson; Kenneth E Hill; Blair L Wood; Ikuo Tsunoda; Noel G Carlson
Journal:  J Neuropathol Exp Neurol       Date:  2010-10       Impact factor: 3.685

4.  Isolation and expression pattern of human Unc-33-like phosphoprotein 6/collapsin response mediator protein 5 (Ulip6/CRMP5): coexistence with Ulip2/CRMP2 in Sema3a- sensitive oligodendrocytes.

Authors:  D Ricard; V Rogemond; E Charrier; M Aguera; D Bagnard; M F Belin; N Thomasset; J Honnorat
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

5.  Systemic and anti-neuronal auto-antibodies in patients with paraneoplastic neurological disease.

Authors:  J W Moll; H Hooijkaas; B C van Goorbergh; L G Roos; S C Henzen-Logmans; C J Vecht
Journal:  J Neurol       Date:  1996-01       Impact factor: 4.849

Review 6.  Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain.

Authors:  R B Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

7.  Autoantibodies to neuronal glutamate receptors in patients with paraneoplastic neurodegenerative syndrome enhance receptor activation.

Authors:  L C Gahring; R E Twyman; J E Greenlee; S W Rogers
Journal:  Mol Med       Date:  1995-03       Impact factor: 6.354

8.  Paraneoplastic encephalo-myelo-ganglionitis: cellular binding sites of the antineuronal antibody.

Authors:  M Yamada; A Inaba; M Yamawaki; K Ishida; T Yokota; T Uchihara; Y Eishi; R Okeda
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

9.  Uptake of systemically administered human anticerebellar antibody by rat Purkinje cells following blood-brain barrier disruption.

Authors:  J E Greenlee; J B Burns; J W Rose; K A Jaeckle; S Clawson
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

10.  Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes.

Authors:  J Honnorat; J C Antoine; E Derrington; M Aguera; M F Belin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-09       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.